Advertorial: Introducing Tor-Bac
Alison Stevenson, Managing Director and Head of R&D at Tor-Bac, explains why this single-dose product has experienced year-on-year sales growth since its introduction to the UK market in 2018. Stevenson
Alison Stevenson, Managing Director and Head of R&D at Tor-Bac, explains why this single-dose product has experienced year-on-year sales growth since its introduction to the UK market in 2018. Stevenson
The latest research highlights from Professor Sebastian Cotofana Key Takeaways • Aesthetic providers educate themselves most frequently via social media, i.e. Instagram and TikTok.• High-volume accounts on social media, aka
Eleanor Hartley, MSc Clinical Dermatology, explains how to achieve structural excellence through integrated skincare Clinical objectives in medical aesthetics have fundamentally evolved. While neuromodulators remain the gold standard for dynamic lines, monotherapy often falls short of meeting modern demands for …
Galderma explores the role of Restylane SkinboostersTM in structured treatment cycles for deep hydration and sustained skin quality improvement For many patients, ‘good skin’ is no longer just about smoothing a line or filling a fold. Increasingly, they are asking …
Three practitioners discuss clinical protocols for décolletage rejuvenation The décolletage presents a unique treatment challenge due to its thin skin, limited adnexal structures and cumulative exposure to ultraviolet radiation.1,2 While topical skincare and energy-based devices (EBDs) can improve surface pigmentation …
Clinical educator Rian Seo argues why ‘training room myths’ regarding leftover PNs can compromise sterility, ethical practice and regulatory compliance The UK aesthetics market is currently defined by a ‘regenerative gold rush,’ with recent specialty data indicating a 25% year-on-year …
Dr Jessica Halliley illustrates a typical day as a clinic owner alongside mentoring work and KOL duties A typical working day… My day starts with uniforms, packed lunches and the school run. With two children under 10, I am on …
Harnessing Sculptra body to address skin quality concerns beyond the face Sculptra is made with the unique PLLA-SCA™, its proprietary form of poly-L-lactic acid (PLLA).1,2,3 Slow degradation of Sculptra’s PLLA-SCA™ provides continuous regenerative biostimulation, characterised by early onset of tissue …
The British Skin Foundation (BSF) promotes a simple, consistent approach to sun protection Skin cancer is the most common cancer in the UK, yet it is largely preventable. For aesthetic practitioners, this presents a clear opportunity to influence patient behaviour …
Four practitioners consider the evolving role of skin boosters in skin health optimisation Skin boosters are injectable formulations, most commonly based on non or lightly cross-linked hyaluronic acid (HA), designed to improve skin quality rather than alter facial contours. Unlike …